July 1, 2016 • By Richard Quinn
Most patients with gout understand the basics of their condition, but only a minority recognizes the importance of achieving and maintaining their serum urate (SU) goals, according to anarticle accepted for publication in Arthritis Care & Research.1
“Knowledge for the other five questions was quite good. The lowest correct response rate was 62% and highest was 90%,” Dr. Mikuls says. “The majority of patients knew these other important elements of their disease … but they had very little knowledge of what the SU target was for a therapy (allopurinol) they already were on.”
Digging deeper into the study results, SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status. Dr. Mikuls says the study shines a light on a gap in patient education.
“You need a well-informed patient. You need a proactive healthcare team. Both are key elements to doing things optimally,” he says. “We have gaps, not only in patient knowledge, but also in provider practices, and that has been shown in the literature. So it’s not going to be an easy problem to tackle. But I think this study shows that, on the patient end, this is a gap we need to begin filling if we are going to do this better.”
Dr. Mikuls recommends starting with the ACR guidelines, which suggest providers impart such knowledge to patients with gout.
“I think the physician taking the time to explain why different therapies are used and the goals of those different therapies are really key to successful gout management,” Dr. Mikuls says. “I think if patients understand that and are engaged in that, it can make a big difference.”
Richard Quinn is a freelance writer in New Jersey.
- Coburn BW, Bendlin KA, Sayles H, et al. Target serum urate: Do gout patients know their goal? Arthritis Care Res (Hoboken). 2016 Jan 19. doi: 10.1002/acr.22785. [Epub ahead of print]